Condition
Osteoarticular Infection
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT01815541Phase 2CompletedPrimary
Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study
NCT06627842RecruitingPrimary
OsteoArticular Sepsis in Intensive Care unitS
NCT05046860Not ApplicableRecruitingPrimary
Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements
NCT02599493Phase 4CompletedPrimary
EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin
NCT01500837Not ApplicableCompletedPrimary
Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)
Showing all 5 trials